← All companies
Intellia Therapeutics, Inc.
NTLA - CIK 0001652130
Market cap$1.70 B
Rank#2213
SEC filings687
Market capitalization of Intellia Therapeutics, Inc.
As of 2026-06-11, Intellia Therapeutics, Inc. (NTLA) has a market capitalization of $1.70 B, making it the #2213 most valuable US-listed company.
Recent market cap readings
| Date | Market cap |
|---|---|
| 2026-06-11 | $1.70 B |
| 2026-06-10 | $1.73 B |
| 2026-05-29 | $1.95 B |
| 2026-05-28 | $1.88 B |
| 2026-05-26 | $1.76 B |
| 2026-05-25 | $1.76 B |
| 2026-05-24 | $1.76 B |
| 2026-05-22 | $1.76 B |
Readings accumulate daily as market data refreshes, combining SEC-reported share counts with live prices.
Market Cap of similar companies
Frequently asked questions
What is Intellia Therapeutics, Inc.'s market cap?
As of 2026-06-11, Intellia Therapeutics, Inc. (NTLA) has a market capitalization of $1.70 B, making it the #2213 most valuable US-listed company.
Where does Intellia Therapeutics, Inc. rank by market cap?
Intellia Therapeutics, Inc. is the #2213 largest US-listed company by market capitalization.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.